Shaolin Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Shaolin Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-267,599	Closed	-$5.38K	–	321
2024 Q2	$5.38K	Hold	267,599	–	–	﹤0.01%	313
2024 Q1	$18.3K	Sell	267,599 -23,400	-8%	-$1.42K	﹤0.01%	243
2023 Q4	$6.84K	Sell	290,999 -83,999	-22%	-$2.62K	﹤0.01%	372
2023 Q3	$27K	Buy	+374,998	New	+$26.8K	﹤0.01%	375
2023 Q2	–	Sell	-374,998	Closed	-$16.3K	–	716
2023 Q1	$15K	Hold	374,998	–	–	﹤0.01%	589
2022 Q4	$16K	Buy	+374,998	New	+$19.7K	﹤0.01%	608

Other funds holding CEROW

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $9.6B AUM 50.48% 1-Year Est. Return